IDiyas

For the Inventor, By the Inventor

Watchung, NJ, United States of America

Leeyuan Huang

USPTO Granted Patents = 17

Average Co-Inventor Count = 4.2

ph-index = 7

Forward Citations = 143(Granted Patents)


Location History:

  • Westfield, NJ (US) (1983 - 1987)
  • Watchung, NJ (US) (1989 - 1999)

Company Filing History:

goldMedal17 out of 4,770 
 
Merck + Co., Inc.
 patents

Years Active: 1983-1999

Loading Chart...
17 patents (USPTO):
1. 5994412 - Bis-aryl ethers, compositions containing such compounds and methods of (1999-11-30),
2. 5468771 - Cholesterol lowering compound (1995-11-21),
3. 5362752 - Chemical compounds (1994-11-08),
4. 5359096 - Cholesterol lowering compounds (1994-10-25),
5. 5283256 - Cholesterol-lowering agents (1994-02-01),
6. 5270332 - Cholesteral lowering agents (1993-12-14),
7. 5194378 - Process for producing FK-506 (1993-03-16),
8. 5132320 - Squalene synthetase inhibitors (1992-07-21),
9. 5102907 - Novel squalene synthetase inhibitors (1992-04-07),
10. 5096923 - Novel squalene synthetase inhibitors (1992-03-17),
11. 4981980 - Drug for treating manic depression (1991-01-01),
12. 4980283 - Renin-inhibitory pepstatin phenyl derivatives (1990-12-25),
13. 4874745 - Renin-inhibitory pepstatin phenyl derivatives (1989-10-17),
14. 4814324 - Sterol inhibitors of testosterone 5.alpha.-reductase (1989-03-21),
15. 4639466 - 3',6-diisopentenyl-2',4'-dihydroxy-5,7-dimethoxy-isoflavan and related (1987-01-27),

Title: The Innovative Journey of Leeyuan Huang: A Patent Prolific Inventor

Introduction: Leeyuan Huang, an esteemed inventor based in Watchung, New Jersey, has made remarkable contributions to the field of pharmaceuticals and organic compounds. With a total of 17 patents to his name, Huang has been at the forefront of innovative research and development.

Latest Patents: Among his latest inventions is a patent for bis-aryl ethers, which describe compositions containing compounds with the formula I, portraying significant inhibitory activity against the oncoprotein Raf. This research has important implications for cancer treatment, as it includes pharmaceutical compositions, methods of treating cancers, cultures of the producing fungal microorganism, and innovative methods for the fermentative production of the compound. Additionally, he has developed a cholesterol-lowering compound that adds to his impressive portfolio of patents.

Career Highlights: Leeyuan Huang is currently associated with Merck & Company, Inc., where he utilizes his expertise to contribute to groundbreaking pharmaceutical innovations. His dedication to research and development has not only advanced clinical applications but also showcased the significance of innovative thinking in the pharmaceutical industry.

Collaborations: Throughout his career, Huang has worked alongside esteemed colleagues such as Otto D. Hensens and John G. MacConnell. These collaborations have enabled him to share knowledge and expertise, further enhancing the impact of their collective research endeavors.

Conclusion: Leeyuan Huang's journey as an inventor is characterized by his passion for innovation and a commitment to improving healthcare through his discoveries. As he continues to develop impactful compounds and methods, his contributions are sure to leave a lasting legacy in the field of pharmaceuticals.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…